# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-23-003635
Filing Date
2023-02-15
Accepted
2023-02-15 08:34:46
Documents
17
Period of Report
2023-02-10
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | arwr-20230210.htm iXBRL | 8-K | 39840
2 | EX-99.1 | nr-xjnjx0795aroxpnpla3ri.htm | EX-99.1 | 10650
6 |  | nr-xjnjx0795aroxpnpla3ri001.jpg | GRAPHIC | 186027
7 |  | nr-xjnjx0795aroxpnpla3ri002.jpg | GRAPHIC | 203249
8 |  | nr-xjnjx0795aroxpnpla3ri003.jpg | GRAPHIC | 263617
9 |  | nr-xjnjx0795aroxpnpla3ri004.jpg | GRAPHIC | 85927
| Complete submission text file | 0001628280-23-003635.txt |  | 1215096

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | arwr-20230210.xsd | EX-101.SCH | 1929
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | arwr-20230210_lab.xml | EX-101.LAB | 24849
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | arwr-20230210_pre.xml | EX-101.PRE | 13064
11 | EXTRACTED XBRL INSTANCE DOCUMENT | arwr-20230210_htm.xml | XML | 11265

Mailing Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105
Business Address 177 E COLORADO BLVD SUITE 700 PASADENA CA 91105 626-696-4702
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 23633751
SIC: 2834 Pharmaceutical Preparations